Global Panic Attack Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

Description

Global Panic Attack Treatment Market is expected to reach US$ 6.34 Bn by 2030, from US$ 2.14 Bn in 2023, exhibiting a CAGR of 16.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 2.14 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	16.80%	2030 Value Projection:	US$ 6.34 Bn

Figure 1. Global Panic Attack Treatment Market Share (%), By Region, 2023

Global Panic Attack Treatment Market - IMG1

Panic attacks are intense episodes of sudden fear or distress that can be debilitating for individuals who experience them. These attacks often come without warning, and can cause physical symptoms such as heart palpitations, shortness of breath, and chest pain. Panic attack treatment focuses on relieving symptoms, reducing the frequency of attacks, and improving overall quality of life.

Market Dynamics:

Global panic attack treatment market is expected to witness significant growth in the near future. The global market growth is driven by several factors including the increasing prevalence of panic disorders worldwide. Rising awareness about mental health, coupled with the growing acceptance and understanding of panic attacks, are also contributing to market growth. Advancements in medical technology and therapeutic interventions have led to the development of more effective treatments for panic attacks. For instance, according to the Anxiety and Depression Association of America (ADAA), in 2020, anxiety disorders are the most common mental illness in the U.S. that affects nearly 40 million adults (18.1%) in the U.S. aged 18 years and older, every year. According to the same source, generalized anxiety disorder (GAD) affects 6.8 million adults, or 3.1% of the U.S. population and panic disorder (PD) affects 6 million adults, or 2.7% of the U.S. population, each year.

However, there are certain factors that may restrain the market growth. One of the key challenges in this market is the stigma associated with mental health issues including panic attacks. This stigma often prevents individuals from seeking help and treatment. Moreover, the high cost of panic attack treatments and a lack of reimbursement policies in some regions are also potential barriers to the market growth.

Despite these challenges, several opportunities exist in the market. There is a growing demand for personalized and targeted therapies that can effectively manage panic attacks. Moreover, the integration of virtual reality technology and artificial intelligence in panic attack treatment is expected to open new avenues for market expansion. Increasing investments in research and development activities by key players in the pharmaceutical industry are likely to boost innovation in this market and create growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global panic attack treatment market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key players in the global panic attack treatment market likeGlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Johnson & Johnson Services, Inc., Bausch Health Companies Inc., and H. Lundbeck A/S are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies
Insights from this report would allow marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
The global panic attack treatment market report caters to various stakeholders, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts in the industry
Stakeholders can benefit from various strategy matrices used in analyzing the global panic attack treatment market, which would facilitate ease in decision-making

Detailed Segmentation:

By Drug Class
- Antidepressants
- Anti-anxiety Drugs
- CGRP Antagonists
- Others
By Route of Administration
- Oral
- Intravenous
- Intramuscular
- Sublingual
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Global Panic Attack Treatment Market:
- GlaxoSmithKline plc.
- F.Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
- Bausch Health Companies Inc.
- Lundbeck A/S

Product Code: CMI6460

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of anxiety and panic disorders
- Restraints
Side effects and safety issues with medications
- Opportunities
Growing use of telemedicine and e-therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Panic Attack Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Panic Attack Treatment Market, By Drug Class, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Anti-anxiety Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
CGRP Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Panic Attack Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Panic Attack Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019- 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Panic Attack Treatment Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,( US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
Teva Pharmaceutical Industries Ltd.
Eli Lilly and Company
Bristol-Myers Squibb Company
AstraZeneca
Pfizer Inc.
Johnson & Johnson Services, Inc.
Bausch Health Companies Inc.
Lundbeck A/S
Analyst Views

10. Section

Research Methodology
About us